This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
FEMYSO
LUPIN PHARMA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of FEMYSO in Canada?
Yes. FEMYSO 200MCG 200MG has an active shortage reported to Health Canada (last updated November 6, 2026).
Why is FEMYSO not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will FEMYSO be available again?
The estimated resolution date (November 12, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02560569
Strength
200MCG 200MG
Dosage Form
TABLET KIT
Route
BUCCAL ORAL
Active Ingredient
MISOPROSTOL MIFEPRISTONE
Tier
Unrated
Last Updated
2026-09-02
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
FEMYSO has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from LUPIN PHARMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
0.35MG · DIN 02441306
DIN 02424282
DIN 02424290
500MG · DIN 02471159
250MG · DIN 02469189
125MG · DIN 02469170
250MG · DIN 02471140
2MG · DIN 02449064
1MG · DIN 02449056
0.5MG · DIN 02449048
240MG · DIN 02559323
480MG · DIN 02559331